South San Francisco, CA, United States of America

Randall Brezski

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Genentech, Inc.. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Randall Brezski

Introduction

Randall Brezski is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding complexes. His work has implications for enhancing agonistic activity in various applications.

Latest Patents

Randall Brezski holds a patent titled "Antigen binding complex having agonistic activity and methods of use." This patent describes antigen binding polypeptides and complexes that exhibit agonist activity. The patent also outlines methods for screening complexes or polypeptides with agonist activity, enhancing the agonist activity of a polypeptide, and utilizing these complexes and polypeptides to agonize a cell surface receptor.

Career Highlights

Brezski is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His role at Genentech allows him to collaborate with other talented professionals in the field, contributing to groundbreaking research and advancements.

Collaborations

Some of his notable coworkers include Greg Lazar and Jeong Kim. Their collaborative efforts in research and development have furthered the understanding and application of antigen binding technologies.

Conclusion

Randall Brezski's work exemplifies the spirit of innovation in biotechnology. His patent and contributions to Genentech highlight the importance of research in developing new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…